Skip to content

Insider · CIK 0001688327

Third Rock Ventures IV, L.P.

owner

Files at TNGX (Tango Therapeutics, Inc.), MAZE (Maze Therapeutics, Inc.). First filing Aug 21, 2025, latest Oct 27, 2025.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 6
$0 bought, $26M sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

TNGX: Tango Therapeutics, Inc.

TNGXOct 9, 2026 · close 23.81

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
37Weak
TNGXsell
Tango Therapeutics, Inc.
$4.8M
477,401 shares
-3%+585% from low-21% from high
37Weak
TNGXsell
Tango Therapeutics, Inc.
$4.0M
500,000 shares
-3%+625% from low0% from high
37Weak
TNGXsell
Tango Therapeutics, Inc.
$2.6M
363,541 shares
-2%+568% from low-24% from high
37Weak
TNGXsell
Tango Therapeutics, Inc.
$5.1M
729,365 shares
-5%+531% from low-34% from high
37Weak
TNGXsell
Tango Therapeutics, Inc.
$2.1M
302,194 shares
-2%+527% from low-34% from high
37Weak
TNGXsell
Tango Therapeutics, Inc.
$7.7M
1,100,000 shares
-7%+533% from low-34% from high

Transactions

Every row this insider has filed, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Nov 4, 2025MAZE
Maze Therapeutics, Inc.
JOther
Common Stock
-1,600,000--4,473,958Nov 5, 2025
Oct 23, 2025TNGX
Tango Therapeutics, Inc.
SOpen-market sale
Common Stock
-477,401$10.15$4.8M13,386,574Oct 27, 2025
Sep 25, 2025TNGX
Tango Therapeutics, Inc.
SOpen-market sale
Common Stock
-500,000$8.02$4.0M13,863,975Sep 29, 2025
Sep 16, 2025TNGX
Tango Therapeutics, Inc.
SOpen-market sale
Common Stock
-363,541$7.04$2.6M14,363,975Sep 17, 2025
Sep 5, 2025TNGX
Tango Therapeutics, Inc.
SOpen-market sale
Common Stock
-642,906$7.00$4.5M14,813,975Sep 9, 2025
Sep 8, 2025TNGX
Tango Therapeutics, Inc.
SOpen-market sale
Common Stock
-86,459$7.04$609k14,727,516Sep 9, 2025
Aug 22, 2025TNGX
Tango Therapeutics, Inc.
SOpen-market sale
Common Stock
-302,194$7.00$2.1M15,456,881Aug 26, 2025
Aug 19, 2025TNGX
Tango Therapeutics, Inc.
SOpen-market sale
Common Stock
-1,100,000$7.01$7.7M15,759,075Aug 21, 2025

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Third Rock Ventures IV, L.P.: insider trades and track record | InsiderTell